Skip to content

Clinical trials

Phase 2 Neurologic Manifestations trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Neurologic Manifestations Phase: Phase 2 Country / region: United States Clear all

27 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20021
20041
20062
20071
20081
20091
20102
20112
20121
20132
20141
20152
20211
20221
20231
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed16
Terminated4
Suspended2
Unknown status2
Withdrawn2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)3
Northwestern University3
H. Lee Moffitt Cancer Center and Research Institute2
Novartis2
Brigham and Women's Hospital1
Duke University1
Institute for Neurodegenerative Disorders1
Medicure1
National Cancer Institute (NCI)1
National Center for Research Resources (NCRR)1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Neurologic Manifestations27
Nervous System Diseases10
Central Nervous System Diseases6
Brain Neoplasms5
Mental Disorders5
Rare Diseases4
Bone Diseases3
Bone Diseases, Metabolic3
Brain Diseases3
Musculoskeletal Diseases3

Trials

Showing 1 to 25 of 27. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.